Nudges for Smoking Cessation in Mental Illness
(ISRAISE Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a new method to help individuals with serious mental illness quit smoking. It tests an approach called "Nudges to Quit," which includes reminders and support from a care team, such as case workers and pharmacists, to encourage quitting. Some participants will receive usual care, while others will get these additional nudges. Suitable candidates have a serious mental illness, smoke more than five cigarettes daily, and have not recently received tobacco treatment. As an unphased trial, this study provides a unique opportunity to contribute to innovative research that could develop new support methods for quitting smoking.
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications. However, you cannot participate if you have used tobacco treatment medications or counseling in the past 30 days.
What prior data suggests that the "Nudges to Quit" intervention is safe for smoking cessation in patients with serious mental illness?
Research has shown that nudges are generally safe and well-tolerated. In studies, these gentle reminders and prompts have helped people adopt healthier habits, such as quitting smoking. The goal is to encourage better choices in a supportive way.
Reports of harmful side effects from nudges do not exist. Instead, these methods aim to increase engagement with treatments safely, making them a low-risk option for helping people stop smoking. For those considering joining a trial that uses nudges, current evidence suggests they are safe.12345Why are researchers excited about this trial?
Researchers are excited about the "Nudges to Quit" approach for smoking cessation in individuals with mental illness because it offers a unique way to enhance engagement with tobacco treatment. Unlike traditional methods that often rely on self-initiated quitting or pharmacotherapy like nicotine replacement therapies, this strategy employs reminders to the care team, creating a supportive network that actively encourages patients to quit smoking. This multilevel intervention aims to increase patient interaction with smoking cessation resources, potentially leading to better engagement and outcomes.
What evidence suggests that this trial's treatments could be effective for smoking cessation in mental illness?
Research has shown that "nudges," which participants in this trial may receive, can help adults reduce tobacco and alcohol use. In a study on smoking, these gentle reminders and prompts reduced smoking rates in some communities. This trial will compare the effectiveness of "Nudges to Quit," designed to increase participation in tobacco treatment, with Usual Care. By reminding both patients and their healthcare teams, nudges aim to support smoking cessation. Although promising, further studies are needed to confirm their effect on helping people with serious mental illness stop smoking.678910
Who Is on the Research Team?
Li-Shiun Chen, M.D., MPH, ScD
Principal Investigator
Washington University School of Medicine
Are You a Good Fit for This Trial?
This trial is for adults over 18 who are patients at a participating clinic, speak and understand English, and currently smoke more than five cigarettes per day. It's not for those actively using or prescribed smoking cessation medication in the past month.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
All patients receive a pre-appointment tobacco treatment needs assessment with patient input as decision support for their care team
Treatment
Patients are randomized to either usual care or the 'Nudges to Quit' intervention, with follow-up surveys at 3 and 6 months
Follow-up
Participants are monitored for smoking behaviors and treatment engagement after the intervention
What Are the Treatments Tested in This Trial?
Interventions
- Nudges
- Usual Care
Find a Clinic Near You
Who Is Running the Clinical Trial?
Washington University School of Medicine
Lead Sponsor
National Cancer Institute (NCI)
Collaborator